ZA962214B - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- ZA962214B ZA962214B ZA962214A ZA962214A ZA962214B ZA 962214 B ZA962214 B ZA 962214B ZA 962214 A ZA962214 A ZA 962214A ZA 962214 A ZA962214 A ZA 962214A ZA 962214 B ZA962214 B ZA 962214B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA952938 | 1995-04-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA962214B true ZA962214B (en) | 1996-10-07 |
Family
ID=25584993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA962214A ZA962214B (en) | 1995-04-10 | 1996-03-19 | Pharmaceutical composition |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5155096A (en) |
WO (1) | WO1996032135A1 (en) |
ZA (1) | ZA962214B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH692322A5 (en) | 1997-05-26 | 2002-05-15 | Westy Ag | clear injectable formulation of propofol. |
IN187686B (en) * | 2000-06-21 | 2002-06-08 | Bharat Serums & Vaccines Ltd | |
PE20020300A1 (en) | 2000-08-22 | 2002-05-10 | Pharmacia Corp | COMPOSITION OF SOLUTION OF AN ANTIBIOTIC DRUG BASED ON OXAZOLIDINONE WITH IMPROVEMENT OF DRUG LOAD |
AR031135A1 (en) | 2000-10-10 | 2003-09-10 | Upjohn Co | TOPIC ANTIBIOTIC COMPOSITIONS FOR THE TREATMENT OF OCULAR INFECTIONS |
US7034013B2 (en) | 2001-03-20 | 2006-04-25 | Cydex, Inc. | Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
US20030055023A1 (en) * | 2001-03-20 | 2003-03-20 | Rajewski Roger A. | Formulations containing etomidate and a sulfoalkyl ether cyclodextrin |
US6887866B2 (en) | 2002-01-25 | 2005-05-03 | Theravance, Inc. | Short-acting sedative hypnotic agents for anesthesia and sedation |
ATE326985T1 (en) * | 2002-02-01 | 2006-06-15 | Shimoda Biotech Pty Ltd | LYOPHILIZED PHARMACEUTICAL COMPOSITION OF PROPOFOL |
SI1648413T1 (en) | 2003-07-23 | 2010-01-29 | Theravance Inc | Pharmaceutical compositions of short-acting sedative hypnotic agent |
CN1909893A (en) * | 2004-01-14 | 2007-02-07 | 株式会社大塚制药工场 | Propofol-containing fat emulsion preparation |
AU2006310044A1 (en) * | 2005-08-12 | 2007-05-10 | Bharat Serums & Vaccines Ltd. | Aqueous anaesthetic compositions comprising propofol |
DK2484350T3 (en) * | 2011-02-04 | 2016-08-01 | Norbert Univ -Prof Dr Med Roewer | A pharmaceutical composition containing a complex of a cyclodextrin with a propofolsalt |
CN107261152B (en) | 2011-11-29 | 2022-03-04 | 优奥斯私人有限公司 | Method for preserving injectable pharmaceutical compositions comprising cyclodextrins and hydrophobic drugs |
KR102147084B1 (en) | 2012-11-15 | 2020-08-24 | 자피오텍 게엠베하 | Delphinidin complex as an antiphlogistic or immunosuppressive active ingredient |
EP2931287B1 (en) | 2012-12-11 | 2017-10-04 | Sapiotec GmbH | Delphinidin for combating melanoma cells |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993017711A1 (en) * | 1992-03-11 | 1993-09-16 | Australian Commercial Research & Development Limited | New cyclodextrins and new formulated drugs |
-
1996
- 1996-03-19 ZA ZA962214A patent/ZA962214B/en unknown
- 1996-03-27 WO PCT/GB1996/000737 patent/WO1996032135A1/en active Application Filing
- 1996-03-27 AU AU51550/96A patent/AU5155096A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU5155096A (en) | 1996-10-30 |
WO1996032135A1 (en) | 1996-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9601698D0 (en) | Pharmaceutical composition | |
HUP9802999A3 (en) | Pharmaceutical composition containing n-propargyl-1-aminoindan | |
ZA967827B (en) | Pharmaceutical compositions | |
GB9519667D0 (en) | Pharmaceutical composition | |
ZA962214B (en) | Pharmaceutical composition | |
ZA963590B (en) | Pharmaceutical composition | |
EG24294A (en) | Pharmaceutical compositions | |
GB9506382D0 (en) | Pharmaceutical compositions | |
GB9513972D0 (en) | Pharmaceutical compositions | |
ZA96525B (en) | Novel pharmaceutical compositions | |
ZA9610426B (en) | Pharmaceutical composition | |
GB9502695D0 (en) | Pharmaceutical composition | |
ZA964193B (en) | Pharmaceutical composition | |
HUP9602822A2 (en) | Pharmaceutical composition | |
ZA963591B (en) | Pharmaceutical composition | |
ZA95736B (en) | Pharmaceutical composition | |
HUP9602732A3 (en) | Pharmaceutical composition comprising lanperisone | |
GB9514807D0 (en) | Pharmaceutical composition | |
HU9903430D0 (en) | Pharmaceutical composition | |
ZA9510132B (en) | Pharmaceutical composition | |
GB9507038D0 (en) | Pharmaceutical composition | |
GB9515207D0 (en) | Pharmaceutical composition | |
GB9515208D0 (en) | Pharmaceutical composition | |
GB9517063D0 (en) | Pharmaceutical composition | |
GB9507037D0 (en) | Pharmaceutical composition |